Tag: nominal
PHARNEXT: Information relating to the total number of voting rights and shares making up the share capital and the nominal value of the shares – 09/06/2023 at 6:00 p.m.
PARIS, France, SEPTEMBER 6, 2023 at 6 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a biopharmaceutical company at an advanced clinical stage developing new therapies for neurodegenerative…
ADOMOS: ADOMOS – Coming into effect of the consolidation of Buy-Louer.fr shares / Definitive completion of the share capital reduction motivated by losses by way of reduction of the nominal value of the Company’s shares – 04/09/2023 at 6:00 p.m.
Paris, September 4, 2023 At 18 hours Effective date of the consolidation of Adomos shares Decision to reduce the share capital motivated by losses by reducing the par value of…
NEOVACS: Adjustment of the nominal value – 2023-09-04 at 20:00
Suresnes, September 4, 2023 – 8:00 p.m. CET – The Board of Directors of NEOVACS (Euronext Growth Paris: ALNEV), on the basis of the 8 th resolution voted at the…
NOTICE TO HOLDERS OF BONDS CONVERTIBLE/EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL AMOUNT OF 24,999,975.99 EUROS – 08/02/2023 at 6:00 p.m.
PARIS, France, August 2, 2023 – 6:00 p.m. (CET) – Abivax SA (Euronext Paris: FR0012333284 – ABVX), a clinical-stage Phase 3 biotechnology company developing drugs that modulate the immune system…
VERGNET: Nominal reduction and modification of the consolidation parity – 08/02/2023 at 6:25 p.m.
The Vergnet Group decides on a capital reduction motivated by losses by reducing the nominal value of the company’s share and modifies the future consolidation parity Elms, August 2, 2023…
PHARNEXT: Information relating to the total number of voting rights and shares making up the share capital and the nominal value of the shares – 08/01/2023 at 7:00 p.m.
PARIS, France, 1 er August 2023 at 7 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a biopharmaceutical company at an advanced clinical stage developing new therapies for…
GECI International: decreases the nominal value of the shares – 06/27/2023 at 18:27
(CercleFinance.com) – GECI International announces the implementation of a capital reduction by reducing the par value of the Company’s shares from 0.001 euro to 0.0001 euro. This purely technical operation…
EUROPLASMA – Implementation of new bond financing for a maximum nominal amount of 15 million euros over 36 months in the form of OCEANE-BSA bonds and free allocation of stock warrants for the benefit of all shareholders of the society
EUROPLASMA – Implementation of new bond financing for a maximum nominal amount of 15 million euros over 36 months in the form of OCEANE-BSA bonds and free allocation of stock…
NOTICE TO HOLDERS OF BONDS CONVERTIBLE/EXCHANGEABLE FOR NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL AMOUNT OF 24,999,975.99 EUROS – 01/31/2023 at 6:00 p.m.
PARIS, France, January 31, 2023 – 6:00 p.m. (CET) – Abivax SA (Euronext Paris: FR0012333284 – ABVX), Phase 3 clinical-stage biotechnology company developing drugs that modulate the immune system to…
TME Pharma: plan to reduce the nominal value of the share – 01/02/2023 at 11:57
(CercleFinance.com) – TME Pharma will seek the agreement of its shareholders to reduce the nominal value of its share and increase its authorized share capital, the biotechnology company announced on…
EDF announces the success of its hybrid bond issue for a nominal amount of 1 billion euros
By Hector Chaunu Published on 11/30/2022 at 6:59 p.m. Photo credit © EDF …
BREF – EDF announces the success of a multi-tranche senior bond issue for a nominal amount of €3 billion
BREF – EDF announces the success of a multi-tranche senior bond issue for a nominal amount of €3 billion | Photo credits: © EDF / CAPA PICTURES / SIMITCH WLAD…